Pledpharma: Up-listing approval

Research Note

2019-10-17

11:28

The shares of Pledpharma will start to trade on the Nasdaq Stockholm main market from the 31 of October 2019, following the approval of its application yesterday. We believe this is long-term positive for the stock, as Nasdaq Stockholm attracts more attention from domestic and international investors than a First North listing, as it is a broader market with tighter requirements of international accounting and information standards.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.